clinical trial, HIV, adolescents, short-cycle, antiretroviral, dolutegravir
HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial
HIV, adolescents, dolutegravir, short cycle therapy, young people, randomised controlled trial